The Course of Hip Flexion Weakness Following LLIF or ALIF

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

22 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-10-04

Study Completion Date

2027-11-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the course of hip weakness after LLIF or ALIF procedures. These outcomes include measures of hip strength using a dynamometer, which is a device used to measure muscle strength. While it is known that people experience temporary hip and leg weakness after an LLIF or ALIF, the exact timing of when hip and leg strength is regained after an LLIF or ALIF is not known.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Instability in the Lumbar Spine of Patients With Age Related Changes and Narrowing of the Spinal Canal (Spinal Stenosis)

NCT04406987

Degenerative Lumbar Spinal Stenosis Degenerative Spondylolisthesis

COMPLETED

Association Between Lumbar Muscle Atrophy, Sagittal Pelvic Alignment and Stenosis Grade in Patients With Degenerative Lumbar Spinal Stenosis

NCT04444739

Lumbar Spinal Stenosis (LSS)

COMPLETED

Depo-Medrol on Psoas After LLIF

NCT05929755

Muscle Weakness Pain, Postoperative Paresthesia +1 more

RECRUITING PHASE4

Impact of Local Steroid Application in Extreme Lateral Lumbar Interbody Fusion

NCT03327272

Stenosis Herniated Nucleus Pulposus Degenerative Disc Disease +4 more

WITHDRAWN PHASE3

Study Comparing Postoperative Treatment After Surgical Decompression for Lumbar Spinal Stenosis.

NCT05312281

Spinal Stenosis

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Degenerative Disc Disease Herniated Nucleus Pulposus Spondylolisthesis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LLIF or ALIF procedures

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1-, 2-, or 3-level L2L3, L3L4, or L4L5 LLIF or ALIF for degenerative pathology including radiculopathy, neurogenic claudication, intervertebral disc disease, facet joint disease, degenerative spondylolisthesis, degenerative myelopathy degenerative kyphosis, and scoliosis
* Back and/or leg pain
* Failed at least 6 months of conservative treatment

Exclusion Criteria

* Older than 65 years of age
* Prior spinal fusion surgery
* Greater than Grade 2 spondylolisthesis
* Greater than 10° scoliosis
* History of spinal infection

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No